![Out of Patients with Matthew Zachary artwork](https://is4-ssl.mzstatic.com/image/thumb/Podcasts113/v4/a0/b4/47/a0b447cb-a7f0-3021-dfc6-5537d008811d/mza_6408803643404782373.jpg/100x100bb.jpg)
The Immunotherapy Series, Part Three: Policy and the FDA
Out of Patients with Matthew Zachary
English - April 16, 2020 11:00 - 21 minutes - 19.3 MB - ★★★★★ - 45 ratingsHealth & Fitness Society & Culture patient insights offscrip media audio research podcasting vaxon out of patients out of patience social media influencer savvy coop Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: The Immunotherapy Series, Part 2
Next Episode: Craig Delarge: The Digital Mental Health Project
Immunotherapy and Policy. How can the FDA evolve to help advance and support novel approaches to medicine? How does the field of immune-driven diagnostics serve as a case in point for the need for evolution in existing regulatory frameworks?
Special guests:
Chief Executive Officer
Assistant Professor, Department of Immuno-Oncology
Assistant Professor, Department of Pediatrics
City Of Hope
This series is brought to you ad-free by Adaptive Biotechnologies
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.